Controlled Release Formulation

Details for Australian Patent Application No. 2002300863 (hide)

International Classifications

Event Publications

20 February 2003 Application Open to Public Inspection

Published as AU-B-2002300863

8 January 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

8 April 2004 Section 223 Application Received

Euroceltique S.A. An application to extend the time from 09 May 2003 to 09 Jan 2004 in which to pay the renewal fee has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

3 June 2004 Section 223 Application Allowed

Euroceltique S.A. The time in which to pay the renewal fee has been extended to 09 Jan 2004. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

14 October 2004 Application Accepted

Published as AU-B-2002300863

27 January 2005 Opposition Lodged

Hexal Australia Pty Ltd has lodged an opposition against Euroceltique S.A.

6 April 2006 Section 223 Application Received

Euroceltique S.A. An application to extend the time from 10 Mar 2004 to 10 Jan 2006 in which to file search results has been filed . Address for service in Australia - Spruson & Ferguson Level 21 60 Margaret Street Sydney NSW 2000

1 June 2006 Section 223 Application Allowed

Euroceltique S.A. The time in which to file search results has been extended to 10 Jan 2006. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

8 April 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 11 Jan 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2003

22 July 2010 Opposition Lodged under Section 104(4)

Spirit Pharmaceuticals Pty Limited has lodged an opposition against Euroceltique S.A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.